FDA Inspection 1135596 — Corcept Therapeutics Incorporated
The FDA completed an inspection of Corcept Therapeutics Incorporated on Oct 19, 2020 in Redwood City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Redwood City, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)